ONCR / Oncorus, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Oncorus, Inc.
US ˙ OTCPK ˙ US68236R1032
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier13.768.936 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Oncorus, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ONCR / Oncorus, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-05-25 Wanstall Rick 3.777 1,2000 3.777 1,2000 4.532 15 1.7800 2.191 48,35
2022-05-20 Wanstall Rick 1.610 1,2000 1.610 1,2000 1.932
2022-05-19 Wanstall Rick 5.000 1,2900 5.000 1,2900 6.450
2022-05-17 Wanstall Rick 1 1,2000 1 1,2000 1
2022-05-16 Wanstall Rick 20.620 1,1800 20.620 1,1800 24.332
2022-05-13 Wanstall Rick 3.898 1,1500 3.898 1,1500 4.483
2022-05-12 Wanstall Rick 14.094 1,0800 14.094 1,0800 15.222
2021-11-16 Harbin Stephen 15.000 5,7800 15.000 5,7800 86.700
2021-11-16 Harbin Stephen 15.000 5,7970 15.000 5,7970 86.955

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ONCR / Oncorus, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ONCR / Oncorus, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2022-12-30 Flynn James E 61.826 0,2700 61.826 0,2700 16.693 346 0.011 -16.013 -95,93
2022-12-30 Flynn James E 61.826 0,2700 61.826 0,2700 16.693
2022-12-30 Flynn James E 15.220 0,2700 15.220 0,2700 4.109
2022-12-29 Flynn James E 63.107 0,2600 63.107 0,2600 16.408
2022-12-29 Flynn James E 63.108 0,2600 63.108 0,2600 16.408
2022-12-29 Flynn James E 15.538 0,2600 15.538 0,2600 4.040
2022-12-28 Flynn James E 24.757 0,2500 24.757 0,2500 6.189
2022-12-28 Flynn James E 24.757 0,2500 24.757 0,2500 6.189
2022-12-28 Flynn James E 6.096 0,2500 6.096 0,2500 1.524

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ONCR / Oncorus, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2023-06-16 3 Shea Brian J. ONCR Common Stock D 8.541
2022-12-30 2022-12-30 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,2700 -15.220 -4 284.697
2022-12-30 2022-12-30 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,2700 -61.826 -17 1.156.308
2022-12-30 2022-12-30 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,2700 -61.826 -17 1.156.308
2022-12-30 2022-12-29 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,2600 -15.538 -4 299.917
2022-12-30 2022-12-29 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,2600 -63.108 -16 1.218.134
2022-12-30 2022-12-29 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,2600 -63.107 -16 1.218.135
2022-12-30 2022-12-28 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,2500 -6.096 -2 315.455
2022-12-30 2022-12-28 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,2500 -24.757 -6 1.281.242
2022-12-30 2022-12-28 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,2500 -24.757 -6 1.281.242
2022-12-27 2022-12-27 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,2700 -7.136 -2 321.551
2022-12-27 2022-12-27 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,2700 -28.977 -8 1.305.999
2022-12-27 2022-12-27 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,2700 -28.977 -8 1.305.999
2022-12-27 2022-12-22 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,2800 -909 -0 328.687
2022-12-27 2022-12-22 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,2800 -3.693 -1 1.334.976
2022-12-27 2022-12-22 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,2800 -3.692 -1 1.334.976
2022-12-21 2022-12-21 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,3000 -1.513 -0 329.596
2022-12-21 2022-12-21 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,3000 -6.143 -2 1.338.669
2022-12-21 2022-12-21 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,3000 -6.144 -2 1.338.668
2022-12-21 2022-12-20 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,3100 -1.616 -1 331.109
2022-12-21 2022-12-20 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,3100 -6.562 -2 1.344.812
2022-12-21 2022-12-20 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,3100 -6.562 -2 1.344.812
2022-12-21 2022-12-19 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,2900 -10.930 -3 332.725
2022-12-21 2022-12-19 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,2900 -44.394 -13 1.351.374
2022-12-21 2022-12-19 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,2900 -44.394 -13 1.351.374
2022-12-15 2022-12-15 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,3900 -339 -0 343.655
2022-12-15 2022-12-15 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,3900 -1.375 -1 1.395.768
2022-12-15 2022-12-15 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,3900 -1.375 -1 1.395.768
2022-12-15 2022-12-14 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,3800 -943 -0 343.994
2022-12-15 2022-12-14 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,3800 -3.829 -1 1.397.143
2022-12-15 2022-12-14 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,3800 -3.828 -1 1.397.143
2022-12-15 2022-12-13 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock S - Sale I 0,4100 -230 -0 344.937
2022-12-15 2022-12-13 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock S - Sale I 0,4100 -933 -0 1.400.972
2022-12-15 2022-12-13 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock S - Sale I 0,4100 -934 -0 1.400.971
2022-05-25 2022-05-25 4 Wanstall Rick ONCR Common Stock P - Purchase D 1,2000 3.777 5 51.000
2022-05-24 2022-05-20 4 Wanstall Rick ONCR Common Stock P - Purchase D 1,2000 1.610 2 47.223
2022-05-19 2022-05-19 4 Wanstall Rick ONCR Common Stock P - Purchase D 1,2900 5.000 6 45.613
2022-05-19 2022-05-17 4 Wanstall Rick ONCR Common Stock P - Purchase D 1,2000 1 0 40.613
2022-05-16 2022-05-16 4 Wanstall Rick ONCR Common Stock P - Purchase D 1,1800 20.620 24 40.612
2022-05-16 2022-05-13 4 Wanstall Rick ONCR Common Stock P - Purchase D 1,1500 3.898 4 19.992
2022-05-16 2022-05-12 4 Wanstall Rick ONCR Common Stock P - Purchase D 1,0800 14.094 15 16.094
2022-05-12 2022-05-10 4 Wanstall Rick ONCR Employee Stock Option (right to buy) A - Award D 1,15 225.000 225.000
2022-05-12 3 Wanstall Rick ONCR Common Stock D 2.000
2022-03-02 2022-03-01 4 Goldberg John Mayer ONCR Employee Stock Option (right to buy) A - Award D 2,00 84.500 84.500
2022-03-02 2022-03-01 4 Queva Christophe ONCR Employee Stock Option (right to buy) A - Award D 2,00 82.500 82.500
2022-03-02 2022-03-01 4 McCabe John P. ONCR Employee Stock Option (right to buy) A - Award D 2,00 90.000 90.000
2022-03-02 2022-03-01 4 Harbin Stephen ONCR Employee Stock Option (right to buy) A - Award D 2,00 87.500 87.500
2022-03-02 2022-03-01 4 Ashburn Theodore ONCR Employee Stock Option (right to buy) A - Award D 2,00 211.000 211.000
2021-11-22 2021-11-19 4 Ashburn Theodore ONCR Employee Stock Option (right to buy) M - Exercise D 1,81 -32.500 255.768
2021-11-22 2021-11-19 4 Ashburn Theodore ONCR Common Stock M - Exercise D 1,8100 32.500 59 99.352
2021-11-17 2021-11-16 4 Harbin Stephen By Stephen W. Harbin Irrevocable Trust ONCR Common Stock P - Purchase I 5,7800 15.000 87 15.000
2021-11-17 2021-11-16 4 Harbin Stephen ONCR Common Stock P - Purchase D 5,7970 15.000 87 15.000
2021-10-25 2021-10-22 4 Ashburn Theodore ONCR Employee Stock Option (right to buy) M - Exercise D 1,81 -43.707 288.268
2021-10-25 2021-10-22 4 Ashburn Theodore ONCR Common Stock M - Exercise D 1,8100 43.707 79 66.852
2021-07-29 2021-07-27 4 Yanni Barbara ONCR Stock Option (right to buy) A - Award D 12,82 25.000 25.000
2021-06-17 2021-06-16 4 Fenton Mary Kay ONCR Stock Option (right to buy) A - Award D 16,55 12.500 12.500
2021-06-17 2021-06-16 4 EVNIN LUKE ONCR Stock Option (right to buy) A - Award D 16,55 12.500 12.500
2021-06-17 2021-06-16 4 Canute Scott A ONCR Stock Option (right to buy) A - Award D 16,55 12.500 12.500
2021-06-17 2021-06-16 4 Nam Spencer ONCR Stock Option (right to buy) A - Award D 16,55 12.500 12.500
2021-06-17 2021-06-16 4 Finer Mitchell H. ONCR Stock Option (right to buy) A - Award D 16,55 12.500 12.500
2021-06-17 2021-06-15 4 Harbin Stephen ONCR Employee Stock Option (right to buy) A - Award D 16,79 87.125 87.125
2021-06-17 2021-06-16 4 Rubin Eric ONCR Stock Option (right to buy) A - Award D 16,55 25.000 25.000
2021-06-17 2020-12-11 4/A Canute Scott A ONCR Stock Option (right to buy) A - Award D 26,00 25.000 25.000
2021-06-03 2021-06-02 4 Queva Christophe ONCR Common Stock S - Sale D 16,6600 -10.656 -178 47.626
2021-06-03 2021-06-01 4 Queva Christophe ONCR Common Stock S - Sale D 16,6900 -12.899 -215 58.282
2021-05-26 2021-05-24 4 Queva Christophe ONCR Employee Stock Option (right to buy) M - Exercise D 1,81 -35.561 17.781
2021-05-26 2021-05-24 4 Queva Christophe ONCR Common Stock M - Exercise D 1,8100 35.561 64 71.181
2021-05-04 2021-04-30 4 Queva Christophe ONCR Common Stock S - Sale D 16,7600 -800 -13 35.620
2021-05-04 2021-04-30 4 Queva Christophe ONCR Common Stock S - Sale D 15,9400 -22.755 -363 36.420
2021-04-28 2021-04-28 4 Queva Christophe ONCR Common Stock S - Sale D 15,2200 -17.990 -274 59.175
2021-04-28 2021-04-27 4 Queva Christophe ONCR Common Stock S - Sale D 15,0000 -211 -3 77.165
2021-04-28 2021-04-26 4 Queva Christophe ONCR Common Stock S - Sale D 15,0000 -54 -1 77.376
2021-04-09 2021-04-07 4 Ashburn Theodore ONCR Employee Stock Option (right to buy) M - Exercise D 5,32 -4.699 336.546
2021-04-09 2021-04-07 4 Ashburn Theodore ONCR Common Stock M - Exercise D 5,3200 4.699 25 23.145
2021-04-09 2020-12-31 4 Ashburn Theodore ONCR Employee Stock Option (right to buy) M - Exercise D 1,81 -1.900 331.975
2021-04-09 2020-12-31 4 Ashburn Theodore ONCR Common Stock M - Exercise D 1,8100 1.900 3 18.446
2021-04-08 2021-04-06 4 Queva Christophe ONCR Common Stock S - Sale D 15,0100 -5.300 -80 77.430
2021-03-03 2021-03-01 4 McCabe John P. ONCR Employee Stock Option (right to buy) A - Award D 15,85 76.894 76.894
2021-03-03 2021-03-01 4 Goldberg John Mayer ONCR Employee Stock Option (right to buy) A - Award D 15,85 61.063 61.063
2021-03-03 2021-03-01 4 Ashburn Theodore ONCR Employee Stock Option (right to buy) A - Award D 15,85 199.000 199.000
2021-03-03 2021-03-01 4 Queva Christophe ONCR Employee Stock Option (right to buy) A - Award D 15,85 70.109 70.109
2021-02-18 2021-02-17 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock P - Purchase I 19,0000 32.884 625 345.167
2021-02-18 2021-02-17 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock P - Purchase I 19,0000 133.558 2.538 1.401.905
2021-02-18 2021-02-17 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock P - Purchase I 19,0000 133.558 2.538 1.401.905
2020-12-16 2020-12-11 4 Canute Scott A ONCR Stock Option (right to buy) A - Award D 26,00 25.000 25.000
2020-12-09 2020-12-07 4 Harbin Stephen ONCR Employee Stock Option (Right to Buy) A - Award D 27,99 169.000 169.000
2020-10-08 2020-10-06 4 Nam Spencer ONCR Series B Preferred Stock C - Conversion D -1.924 0
2020-10-08 2020-10-06 4 Nam Spencer ONCR Common Stock C - Conversion D 1.924 1.924
2020-10-08 2020-10-06 4 MPM SunStates Fund, L.P. ONCR Series B Preferred Stock C - Conversion I -775.975 0
2020-10-08 2020-10-06 4 MPM SunStates Fund, L.P. ONCR Series A-1 Preferred Stock C - Conversion I -1.783.879 0
2020-10-08 2020-10-06 4 MPM SunStates Fund, L.P. ONCR Common Stock P - Purchase I 15,0000 173.776 2.607 2.849.453
2020-10-08 2020-10-06 4 MPM SunStates Fund, L.P. ONCR Common Stock C - Conversion I 775.975 2.675.677
2020-10-08 2020-10-06 4 MPM SunStates Fund, L.P. ONCR Common Stock C - Conversion I 1.783.879 1.899.702
2020-10-08 2020-10-06 4 MPM BioVentures 2014, L.P. ONCR Series B Preferred Stock C - Conversion I -775.975 0
2020-10-08 2020-10-06 4 MPM BioVentures 2014, L.P. ONCR Series A-1 Preferred Stock C - Conversion I -1.783.879 0
2020-10-08 2020-10-06 4 MPM BioVentures 2014, L.P. ONCR Common Stock P - Purchase I 15,0000 173.776 2.607 2.849.453
2020-10-08 2020-10-06 4 MPM BioVentures 2014, L.P. ONCR Common Stock C - Conversion I 775.975 2.675.677
2020-10-08 2020-10-06 4 MPM BioVentures 2014, L.P. ONCR Common Stock C - Conversion I 1.783.879 1.899.702
2020-10-08 2020-10-06 4 GADICKE ANSBERT ONCR Series B Preferred Stock C - Conversion I 700.453 0
2020-10-08 2020-10-06 4 GADICKE ANSBERT ONCR Series B Preferred Stock C - Conversion I 775.975 0
2020-10-08 2020-10-06 4 GADICKE ANSBERT ONCR Series A-1 Preferred Stock C - Conversion I 1.525.348 0
2020-10-08 2020-10-06 4 GADICKE ANSBERT ONCR Series A-1 Preferred Stock C - Conversion I 1.783.879 0
2020-10-08 2020-10-06 4 GADICKE ANSBERT ONCR Common Stock P - Purchase I 15,0000 151.224 2.268 2.377.025
2020-10-08 2020-10-06 4 GADICKE ANSBERT ONCR Common Stock P - Purchase I 15,0000 173.776 2.607 2.849.453
2020-10-08 2020-10-06 4 GADICKE ANSBERT ONCR Common Stock C - Conversion I 700.453 2.225.801
2020-10-08 2020-10-06 4 GADICKE ANSBERT ONCR Common Stock C - Conversion I 775.975 2.675.677
2020-10-08 2020-10-06 4 GADICKE ANSBERT ONCR Common Stock C - Conversion I 1.525.348 1.525.348
2020-10-08 2020-10-06 4 GADICKE ANSBERT ONCR Common Stock C - Conversion I 1.783.879 1.899.702
2020-10-08 2020-10-06 4 Finer Mitchell H. ONCR Stock Option (right to buy) A - Award D 1,81 42.970 42.970
2020-10-08 2020-10-06 4 EVNIN LUKE ONCR Series B Preferred Stock C - Conversion I -700.449 0
2020-10-08 2020-10-06 4 EVNIN LUKE ONCR Series A-1 Preferred Stock C - Conversion I -1.525.346 0
2020-10-08 2020-10-06 4 EVNIN LUKE ONCR Common Stock P - Purchase I 15,0000 151.225 2.268 2.492.843
2020-10-08 2020-10-06 4 EVNIN LUKE ONCR Common Stock C - Conversion I 700.449 2.341.618
2020-10-08 2020-10-06 4 EVNIN LUKE ONCR Common Stock C - Conversion I 1.525.346 1.641.169
2020-10-08 2020-10-06 4 UBS Oncology Impact Fund L.P. ONCR Series B Preferred Stock C - Conversion D -700.453 0
2020-10-08 2020-10-06 4 UBS Oncology Impact Fund L.P. ONCR Series A-1 Preferred Stock C - Conversion D -1.525.348 0
2020-10-08 2020-10-06 4 UBS Oncology Impact Fund L.P. ONCR Common Stock P - Purchase D 15,0000 151.224 2.268 2.377.025
2020-10-08 2020-10-06 4 UBS Oncology Impact Fund L.P. ONCR Common Stock C - Conversion D 700.453 2.225.801
2020-10-08 2020-10-06 4 UBS Oncology Impact Fund L.P. ONCR Common Stock C - Conversion D 1.525.348 1.525.348
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Partners, L.P. ONCR Series B Preferred Stock C - Conversion I -2.449.761 0
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Series B Preferred Stock C - Conversion I -2.449.761 0
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Series B Preferred Stock C - Conversion I -2.449.761 0
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Series A-1 Preferred Stock C - Conversion I -7.499.999 0
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Series A-1 Preferred Stock C - Conversion I -7.499.999 0
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock P - Purchase I 15,0000 109.612 1.644 312.282
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock P - Purchase I 15,0000 445.194 6.678 1.268.344
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock P - Purchase I 15,0000 445.194 6.678 1.268.344
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Partners, L.P. ONCR Common Stock C - Conversion I 202.670 202.670
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock C - Conversion I 202.670 202.670
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock C - Conversion I 202.670 823.150
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. ONCR Common Stock C - Conversion I 620.480 620.480
2020-10-08 2020-10-06 4 Flynn James E Through Deerfield Private Design Fund III, L.P. ONCR Common Stock C - Conversion I 620.480 620.480
2020-10-05 2020-10-01 4 Queva Christophe ONCR Employee Stock Option (right to buy) A - Award D 15,00 89.725 89.725
2020-10-05 2020-10-01 4 Goldberg John Mayer ONCR Employee Stock Option (right to buy) A - Award D 15,00 56.285 56.285
2020-10-05 2020-10-01 4 Ashburn Theodore ONCR Employee Stock Option (right to buy) A - Award D 15,00 126.624 126.624
2020-10-01 3 Finer Mitchell H. ONCR Common Stock D 303.726
2020-10-01 3 Queva Christophe ONCR Common Stock D 82.730
2020-10-01 3 MPM ASSET MANAGEMENT LLC ONCR Common Stock I 115.823
2020-10-01 3 MPM SunStates GP Managing Member LLC ONCR Common Stock I 115.823
2020-10-01 3 GADICKE ANSBERT ONCR Common Stock I 115.823
2020-10-01 3 Goldberg John Mayer ONCR Common Stock D 2.730
2020-10-01 3 EVNIN LUKE ONCR Common Stock I 115.823
2020-10-01 3 Ashburn Theodore ONCR Common Stock D 16.546
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista